Persson, M.; Andersson, M.K.; Mitani, Y.; Brandwein-Weber, M.S.; Frierson, H.F., Jr.; Moskaluk, C.; Fonseca, I.; Ferrarotto, R.; Boecker, W.; Loening, T.;
et al. Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional Study. Cancers 2022, 14, 3691.
https://doi.org/10.3390/cancers14153691
AMA Style
Persson M, Andersson MK, Mitani Y, Brandwein-Weber MS, Frierson HF Jr., Moskaluk C, Fonseca I, Ferrarotto R, Boecker W, Loening T,
et al. Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional Study. Cancers. 2022; 14(15):3691.
https://doi.org/10.3390/cancers14153691
Chicago/Turabian Style
Persson, Marta, Mattias K. Andersson, Yoshitsugu Mitani, Margaret S. Brandwein-Weber, Henry F. Frierson, Jr., Christopher Moskaluk, Isabel Fonseca, Renata Ferrarotto, Werner Boecker, Thomas Loening,
and et al. 2022. "Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional Study" Cancers 14, no. 15: 3691.
https://doi.org/10.3390/cancers14153691
APA Style
Persson, M., Andersson, M. K., Mitani, Y., Brandwein-Weber, M. S., Frierson, H. F., Jr., Moskaluk, C., Fonseca, I., Ferrarotto, R., Boecker, W., Loening, T., El-Naggar, A. K., & Stenman, G.
(2022). Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional Study. Cancers, 14(15), 3691.
https://doi.org/10.3390/cancers14153691
